SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (11309)11/17/1997 9:34:00 AM
From: CYBERKEN  Read Replies (2) | Respond to of 32384
 
Bought a few more warrants this morning, At the very least, Ligand should recover from an oversold situation from last week (that move started late Fri.). Hope the Lilly drug gets disclosed early in the week, That would get some significant press coverage and possibly move some analysists currently on the fence.



To: Henry Niman who wrote (11309)11/17/1997 2:24:00 PM
From: Andrew H  Respond to of 32384
 
>>Thus, Emily did her share for LGND, by registering 2 shutouts and giving up just 2 goals in 4 games.<<

Glad to hear Emily is following in Nicoles footsteps.

Unfortunately, LGND is not following in the footsteps of either. Henry, you should relax, because I am getting nerwous again. Please tell me how the Dow can be up over 160, and LGND,tho very oversold, is unchanged from yesterday. VERRRY depressing.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News